Home Sentynl Therapeutics

Sentynl Therapeutics

acquired
-
Developer of Therapeutic Drugs for Neurological Disorders
Basic
Enterprise Profile

Basic Information

Sentynl Therapeutics, Inc. is a specialty pharmaceutical company focused on the development of therapies for pain and other central nervous system (CNS) disorders. Our pipeline of drug candidates addresses a variety of inherited orphan and neurological diseases, providing meaningful treatments for patients suffering from these conditions.
Sentynl Therapeutics, Inc.
California,United States of America
15~50 people
January 01, 2014
--

Enterprise Profile

Industrial Sector
New Drug Development
Concept
Rare Diseases Therapeutic Products # Pain
Application Scenarios
Innovative Drugs